Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1990
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 2
1995 1
1997 1
1998 1
2003 2
2004 1
2006 1
2007 2
2008 3
2009 2
2011 1
2012 3
2013 2
2014 4
2015 1
2016 1
2017 3
2018 3
2019 2
2020 3
2021 4
2022 5
2023 1
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease.
Singh D. Singh D. J Neuroinflammation. 2022 Aug 17;19(1):206. doi: 10.1186/s12974-022-02565-0. J Neuroinflammation. 2022. PMID: 35978311 Free PMC article. Review.
However, chronic or uncontrolled inflammatory responses may lead to various neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis, and multiple sclerosis. These diseases have variable cl …
However, chronic or uncontrolled inflammatory responses may lead to various neurodegenerative diseases, including Alzheimer's disease (AD), …
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.
Ng L, Khan F, Young CA, Galea M. Ng L, et al. Cochrane Database Syst Rev. 2017 Jan 10;1(1):CD011776. doi: 10.1002/14651858.CD011776.pub2. Cochrane Database Syst Rev. 2017. PMID: 28072907 Free PMC article. Review.
BACKGROUND: Motor neuron disease (MND), which is also known as amyotrophic lateral sclerosis (ALS), causes a wide range of symptoms but the evidence base for the effectiveness of the symptomatic treatment therapies is limited. ...Treatment for sialorrhoeaA si …
BACKGROUND: Motor neuron disease (MND), which is also known as amyotrophic lateral sclerosis (ALS), causes a wide range …
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
James E, Ellis C, Brassington R, Sathasivam S, Young CA. James E, et al. Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article. Review.
BACKGROUND: Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative condition that may cause dysphagia, as well as limb weakness, dysarthria, emotional lability, and respiratory failure. ...The trial p …
BACKGROUND: Motor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegene …
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Yao RQ, Ren C, Xia ZF, Yao YM. Yao RQ, et al. Autophagy. 2021 Feb;17(2):385-401. doi: 10.1080/15548627.2020.1725377. Epub 2020 Feb 12. Autophagy. 2021. PMID: 32048886 Free PMC article. Review.
Organelle-specific autophagy is one of the major subtypes of autophagy, selectively targeting different organelles for quality control. This type of autophagy includes mitophagy, pexophagy, reticulophagy (endoplasmic reticulum), ribophagy, lysophagy, and nucleophagy. ...In …
Organelle-specific autophagy is one of the major subtypes of autophagy, selectively targeting different organelles for quality control. This …
Artificial intelligence for screening and diagnosis of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Umar TP, Jain N, Papageorgakopoulou M, Shaheen RS, Alsamhori JF, Muzzamil M, Kostiks A. Umar TP, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):425-436. doi: 10.1080/21678421.2024.2334836. Epub 2024 Apr 2. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38563056 Review.
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a rare and fatal neurological disease that leads to progressive motor function degeneration. ...For ALS classification, the pooled sensitivity of AI models was 90.9% (95% CI - 86.5% to 93.9%) with a pooled …
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a rare and fatal neurological disease that leads to progressive mo …
Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysis.
Heidari ME, Nadali J, Parouhan A, Azarafraz M, Tabatabai SM, Irvani SSN, Eskandari F, Gharebaghi A. Heidari ME, et al. J Affect Disord. 2021 May 15;287:182-190. doi: 10.1016/j.jad.2021.03.015. Epub 2021 Mar 12. J Affect Disord. 2021. PMID: 33799036 Review.
BACKGROUND: Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental disorders, like depression, which impacts their function, quality of life, and mobility. ...Subgroup analyses are performed on the severity of depression, instruments of …
BACKGROUND: Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental disorders, like depression, wh …
Unraveling the multifaceted insights into amyotrophic lateral sclerosis: Genetic underpinnings, pathogenesis, and therapeutic horizons.
Sharma R, Khan Z, Mehan S, Das Gupta G, Narula AS. Sharma R, et al. Mutat Res Rev Mutat Res. 2024 Jul-Dec;794:108518. doi: 10.1016/j.mrrev.2024.108518. Epub 2024 Nov 2. Mutat Res Rev Mutat Res. 2024. PMID: 39491718 Review.
Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease, primarily impairs upper and lower motor neurons, leading to debilitating motor dysfunction and eventually respiratory failure, widely known as Lou Gehrig's disease. ...The prevalenc
Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease, primarily impairs upper and lower motor n
Possible etiology and treatment of amyotrophic lateral sclerosis.
Holecek V, Rokyta R. Holecek V, et al. Neuro Endocrinol Lett. 2018 Feb;38(8):528-531. Neuro Endocrinol Lett. 2018. PMID: 29504729 Review.
Amyotrophic Lateral Sclerosis (ALS) is one of the most dangerous and least understood diseases with a pathophysiology that is still largely unknown. ...The bibliography reveals several suspect etiological factors including atherosclerosis, inflammation, tumor
Amyotrophic Lateral Sclerosis (ALS) is one of the most dangerous and least understood diseases with a pathophysiology t
A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis.
Beswick E, Park E, Wong C, Mehta AR, Dakin R, Chandran S, Newton J, Carson A, Abrahams S, Pal S. Beswick E, et al. J Neurol. 2021 Dec;268(12):4510-4521. doi: 10.1007/s00415-020-10203-z. Epub 2020 Sep 10. J Neurol. 2021. PMID: 32910255 Free PMC article. Review.
BACKGROUND: Up to 50% of people with amyotrophic lateral sclerosis (ALS) experience cognitive dysfunction, whilst depression and anxiety are reported in up to 44% and 33%, respectively. ...RESULTS: 216 trials, investigating 26,326 people with ALS, were review …
BACKGROUND: Up to 50% of people with amyotrophic lateral sclerosis (ALS) experience cognitive dysfunction, whilst depre …
Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.
Maurel C, Dangoumau A, Marouillat S, Brulard C, Chami A, Hergesheimer R, Corcia P, Blasco H, Andres CR, Vourc'h P. Maurel C, et al. Mol Neurobiol. 2018 Aug;55(8):6480-6499. doi: 10.1007/s12035-017-0856-0. Epub 2018 Jan 10. Mol Neurobiol. 2018. PMID: 29322304 Review.
Amyotrophic lateral sclerosis (ALS) is a disease caused by the degeneration of motor neurons (MNs) leading to progressive muscle weakness and atrophy. ...It is clear that defects in proteostasis are involved in this type of cellular degeneration, but w
Amyotrophic lateral sclerosis (ALS) is a disease caused by the degeneration of motor neurons (MNs) leading to progressi
48 results